UnitedHealth Group (NYSE:UNH) updated its FY20 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $16.25-16.55 for the period, compared to the Thomson Reuters consensus estimate of $16.43. The company issued revenue guidance of $260-262 billion, compared to the consensus revenue estimate of $261.18 billion.UnitedHealth Group also updated its FY19 guidance to approach $15 EPS.
A number of equities analysts have commented on the stock. Mizuho reiterated a buy rating and issued a $300.00 target price (up from $270.00) on shares of UnitedHealth Group in a report on Tuesday, November 26th. Barclays boosted their target price on shares of UnitedHealth Group from $260.00 to $305.00 and gave the stock an overweight rating in a report on Monday. Jefferies Financial Group downgraded shares of UnitedHealth Group from a buy rating to a hold rating and reduced their target price for the stock from $300.00 to $235.00 in a report on Thursday, October 10th. SunTrust Banks reiterated a buy rating and issued a $335.00 target price (up from $310.00) on shares of UnitedHealth Group in a report on Monday, November 18th. Finally, UBS Group reduced their target price on shares of UnitedHealth Group from $281.00 to $257.00 and set a neutral rating for the company in a report on Thursday, October 17th. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. UnitedHealth Group currently has an average rating of Buy and a consensus price target of $289.39.
Shares of UNH traded down $0.21 during mid-day trading on Monday, hitting $279.66. 2,517,060 shares of the company traded hands, compared to its average volume of 4,483,900. UnitedHealth Group has a 1-year low of $208.07 and a 1-year high of $287.94. The company has a quick ratio of 0.70, a current ratio of 0.70 and a debt-to-equity ratio of 0.67. The company has a market capitalization of $265.15 billion, a PE ratio of 21.71, a price-to-earnings-growth ratio of 1.48 and a beta of 0.64. The business has a 50 day moving average of $258.05 and a 200 day moving average of $245.34.
UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, October 15th. The healthcare conglomerate reported $3.88 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $3.75 by $0.13. UnitedHealth Group had a net margin of 5.57% and a return on equity of 25.30%. The firm had revenue of $60.35 billion for the quarter, compared to the consensus estimate of $59.84 billion. During the same quarter in the prior year, the company posted $3.41 earnings per share. The company’s revenue for the quarter was up 6.7% compared to the same quarter last year. As a group, research analysts expect that UnitedHealth Group will post 14.96 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th will be issued a dividend of $1.08 per share. The ex-dividend date of this dividend is Friday, December 6th. This represents a $4.32 annualized dividend and a dividend yield of 1.54%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 33.54%.
In related news, EVP D Ellen Wilson sold 7,400 shares of the stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $272.77, for a total value of $2,018,498.00. Also, Director Richard T. Burke sold 2,500 shares of the stock in a transaction that occurred on Thursday, September 19th. The stock was sold at an average price of $233.40, for a total transaction of $583,500.00. Following the completion of the transaction, the director now owns 187,979 shares in the company, valued at approximately $43,874,298.60. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 38,577 shares of company stock worth $9,398,080. Corporate insiders own 0.82% of the company’s stock.
About UnitedHealth Group
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Recommended Story: Most Volatile Stocks
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.